[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionControl group: Control group will take four placebo tablets in two separate doses once and then two placebo tablets weekly in a single dose for 7 weeks. \u0651\u0651\u0651They will be followed-up for 10 weeks. Drug and placebo are made by Tehran Darou Pharmaceutical Company.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group:The intervention group will take 800 mg i.e four 200 mg tablets of hydroxychloroquine in two separate doses once; and then 400 mg weekly in a single dose for 7 weeks and will be followed-up for 10 weeks. Drug and placebo are made by Tehran Darou Pharmaceutical Company.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]